JHRML Jmi Hospital Requisite Manufacturing Limited
Pharmaceuticals & Chemicals
Tk 40.7 as of 2026-11-12 14:09:42
Rank 151 of all scored
Data completeness 100%
Data completeness 100%
Score breakdown
Consistency 62
Profitability 24
Solvency 99
Valuation 22
Weights: consistency 30%, profitability 30%, solvency 20%, valuation 20%; then risk flags add or subtract points. Full method
Why this score
Strengths
- Solvency Practically debt-free (loan risk cannot hurt it)
- Valuation Trades near book value (P/NAV 1.15x)
- Ownership Institutions (42.72%) hold more than the public (24.98%)
Concerns
- Consistency EPS rose in only 1 of 4 years (erratic or cyclical)
- Profitability Average ROE only 7.13% (below 10%: capital not working hard)
- Valuation P/E 57.32 is high (above 20)
- Valuation Price is 71% above the Graham fair value (Tk 23.8)
Risk flags
- Category B (low or irregular dividends)
- Mid cap (Tk 200-1,000 cr)
Valuation
P/E
P/E audited
P/E current
P/B
NAV per share
EPS (last audited year)
Graham fair value
Margin of safety
52-week range
11.8% above the low, 30.1% below the high. Near the low is only interesting if profit is intact (see concerns above) and the fall has a temporary cause.
Quality and growth
ROE
ROE avg
ROE min
Profit CAGR
Profit YoY
Net profit
EPS up
Loss years (last ~5)
Dividends and safety
Div years
Dividend yield
Payout
Cash div
D/E
Loans/MCap
Size, liquidity and ownership
MCap
Free float
Daily turnover
Sponsor %
Inst. %
Public %
Foreign %
Shareholding
- Sponsor/director 32.3%
- Institution 42.7%
- Public 25%
Audited history
| Year | EPS (Tk) | NAV/share | Net profit (cr) | Cash div % | Bonus % |
|---|---|---|---|---|---|
| 2021 | 2.5 | 31.49 | 23 | — | — |
| 2022 | 3.25 | 38.84 | 33 | 12.5 | 0 |
| 2023 | 2.41 | 32.12 | 30 | 5 | 0 |
| 2024 | 2.34 | 33.95 | 29 | 10 | 0 |
| 2025 | 1.86 | 35.14 | 23 | 5 | 0 |
Fiscal year ends June. EPS, NAV and profit are as audited by the company and published by DSE. Financials last fetched: 14/11/2026.
Shariah screen (partial)
Business screen and the debt ratio (loans / market cap 4.5%, limit 33%) are automated. Interest income (under 5% of revenue) and cash/investment ratios must be checked in the annual report.
Educational, not investment advice. Verify on DSE and StockNow before making any decision.